Descrizione del progetto
Responsabilizzare i pazienti affetti da HIV con una piattaforma mHealth per l’autogestione
I progressi della digitalizzazione e dell'Internet delle cose hanno stimolato l’innovazione in diversi settori. Nel settore sanitario, questi progressi hanno il potenziale per migliorare la personalizzazione dei pazienti e fornire cure mediche più efficienti e accurate. Tuttavia, l’integrazione di tali tecnologie nell’assistenza sanitaria rimane limitata, principalmente ai livelli più bassi e da parte di pochi fornitori. In questo contesto, il progetto EmERGE, finanziato dall’UE, intende sviluppare una piattaforma mHealth innovativa. Questa piattaforma si concentra sul fornire ai pazienti affetti da HIV con malattia stabile la possibilità di autogestire la propria condizione. Sfruttando le soluzioni mHealth esistenti, i fornitori di servizi sanitari in Spagna e nel Regno Unito gestiranno questa piattaforma. La sua messa in campo offrirà un supporto fondamentale e consentirà ai pazienti di tutta l’UE di entrare in contatto con medici e dottori.
Obiettivo
EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers EATG, the European HIV patient organisation, will provide a direct and deep interaction with representative patients and clinicians from 5 EU countries. The platform and interfaces will be validated in a large study of 3900 patients using a tailored HTA process, MAST, specifically developed for the assessment of mHealth solutions including translatability as a key factor. Based on prior work showing a high uptake rate and use of mHealth in HIV patient populations, EmERGE aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, estimated at 6000 saved per year within this study alone. Patient reported outcomes will be agreed and used in the assessment and development of the system which also aims to increase adherence and enable frailty to be reported using mHealth technology. Innovation will be given priority from the beginning by developing new business models of care provision, targeting key stakeholders in the EU health provider sector, including policymakers and clinicians, while eliciting demand from patients to highlight and initiate the widespread implementation and compensation of mHealth solutions within the timeframe of the project. Guidelines and policy briefs will be produced to evidence the benefits and disseminate the lessons learned to support the uptake of mHealth for self-management of other chronic diseases.
Campo scientifico
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
- social scienceseconomics and businessbusiness and managementbusiness models
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- social scienceseconomics and businesseconomicshealth economics
Parole chiave
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-PHC-2014-single-stage
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
BN2 5BE Brighton
Regno Unito